Off-label use of drugs and medical devices: a review of policy implications

Clinical Pharmacology & Therapeutics, 04/13/2012

Given the contradictory and unresolved expectations of major stakeholders, off–label use remains problematic. It requires a new policy paradigm that can successfully balance the need for innovation against the imperatives of evidence–based practice and finite health–care resources.

Print Article Summary

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List